MeiraGTx Holdings (MGTX) Kompaniya qiymatining sof foydaga nisbati

MeiraGTx Corp (MGTX) brendining ramzi va logotipi

MeiraGTx Holdings plc (MGTX) oftalmologiya va nevrologiya sohalarida ko'p qirrali gen terapiyasi tizimlarini ishlab chiqmoqda hamda ichki ishlab chiqarish orqali xatarlarni kamaytirmoqda. O'sish J&J bilan hamkorlik va gen ekspressiyasini nazorat qilish usullari hisobiga ta'minlanmoqda. AAV platformasiga asoslangan faol R&D loyihalari to'r pardasini davolash uchun inqilobiy yechimlarni tayyorlamoqda. Kompaniyaning foydaga nisbatan narx koeffitsiyenti ushbu ma'lumotlarni tasdiqlaydi, bunda parametr qiymati 10.70 ga tengdir.

MeiraGTx Holdings plc (MGTX): P/E multiplikatori 04.07.2022dan 18.11.2026gacha

MeiraGTx (MGTX) kompaniyasining tahliliy kesimlari

- bozor qiymati va tahlilchilarning maqsadli prognozi:
Kompaniyaning umumiy tahlili:MeiraGTx - MGTX
meiragtx.com tayyor mahsulotlari

MeiraGTx Holdings plc (MGTX) kompaniyasida sun'iy intellektning molekulyar modellashtirishga integratsiyasi va dori vositalari sintezining robotlashtirilishi terapiya ishlab chiqishni tezlashtirmoqda, garchi qimmat klinika sinovlariga bog'liqlik sof foydaga ta'sir ko'rsatayotgan bo'lsa-da. Kompaniyaning harakatlanuvchi P/E ko'rsatkichini tahlil qilish orqali investor bir dollar foydaning bozor qiymatini baholaydi, bu esa aktivning joriy narxi uning haqiqiy kesh oqimini yaratish qobiliyatiga nisbatan asoslangan yoki yo'qligini aniqlashga yordam beradi.

Muhim raqobatchilar

tempus.com - Kapitalizatsiyaning sof foydaga nisbati|P/E multiplikatori QGEN|Biznesning o‘zini qoplash muddati Isis Pharmaceuticals|P/E multiplikatori RGEN (repligen.com)|Bozor narxining sof foydaga nisbati RNA (Avidity Biosciences, Inc.)|CRSP - Narxning foydaga nisbati|Kompaniya qiymatining sof foydaga nisbati WGS (GeneDx)|RARE: P/E multiplikatori|Beam Therapeutics Corp - Kompaniya qiymatining sof foydaga nisbati|Narx-foyda koeffitsiyenti SRPT|twistbioscience.com (TWST) - Biznesning o‘zini qoplash muddati|P/E multiplikatori TXG|NTLA (Intellia) - Kompaniya qiymatining sof foydaga nisbati|Narxning foydaga nisbati Stoke STOK|BioLife (BLFS) - Kapitalizatsiyaning foydaga nisbati|wavelifesciences.com - P/E multiplikatori|Kapitalizatsiyaning sof foydaga nisbati MAZE|SION: P/E multiplikatori|PRME - Biznesning o‘zini qoplash muddati|Narx-foyda koeffitsiyenti TSHA|QURE - Kapitalizatsiyaning sof foydaga nisbati koeffitsiyenti|Narx-foyda koeffitsiyenti RGNX (regenxbio.com)|Solid Biosciences Inc. - Narx-foyda multiplikatori|Narxning foydaga nisbati Ocugen Corp OCGN|Pacific Biosciences of California, Inc. (PACB) - Kapitalizatsiyaning foydaga nisbati|BNTC - Narxning foydaga nisbati|Design Pharma - Bozor narxining sof foydaga nisbati|RCKT (Rocket Pharmaceuticals Inc) - Narx-foyda koeffitsiyenti|4D Molecular Therapeutics (FDMT) - P/E multiplikatori|Narxning foydaga nisbati Lexeo Therapeutics, Inc.|Kapitalizatsiyaning foydaga nisbati Korro Bio, Inc. KRRO|P/E multiplikatori EDIT|Biznesning o‘zini qoplash muddati Silence Therapeutics Corp|Narxning foydaga nisbati proqr.com PRQR|CDXS - Narx-foyda koeffitsiyenti|SGMO - Narxning foydaga nisbati|Kapitalizatsiyaning sof foydaga nisbati koeffitsiyenti Nautilus Biotechnology, Inc. (NAUT)|MGX: P/E multiplikatori|Narx-foyda multiplikatori DTIL|GBIO (Generation Bio) - P/E multiplikatori|Narx-foyda multiplikatori BOLD (boundlessbio.com)|Narx-foyda koeffitsiyenti XCUR (exicuretx.com)|Celsion Corporation - Narx-foyda multiplikatori|P/E multiplikatori PHIO (phiopharma.com)|P/E multiplikatori Mustang Bio, Inc. MBIO|RNAZ: Narx-foyda koeffitsiyenti|BNGO (Bionano Genomics) - Narx-foyda multiplikatori|APDN: P/E multiplikatori|bluebird bio (BLUE) - P/E multiplikatori|Narxning foydaga nisbati ImmunoPrecise Antibodies Ltd.|Kapitalizatsiyaning foydaga nisbati Omega OMGA|P/E multiplikatori OMIC|RGLS - Kapitalizatsiyaning foydaga nisbati|Syros Pharmaceuticals, Inc - Narx-foyda koeffitsiyenti|Biznesning o‘zini qoplash muddati Codex DNA (TBIO)|TCON - Narxning foydaga nisbati|UBX: Narxning foydaga nisbati